论文信息 - Clinical usefulness of D-dimer: evaluation during fibrinolytic treatment of venous thrombosis or myocardial infarction. - 字舞流文

Clinical usefulness of D-dimer: evaluation during fibrinolytic treatment of venous thrombosis or myocardial infarction.

C. Bode | W. Kübler | H. Simank | E. Weber | R. Zimmermann | M. Simon

[1] J. Soria,et al. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism. , 1988, Thrombosis research.

[2] P. Mombaerts,et al. Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis , 1987, Thrombosis and Haemostasis.

[3] D. Rylatt,et al. Measurement of Crosslinked Fibrin Derivatives -Use in the Diagnosis of Venous Thrombosis , 1987, Thrombosis and Haemostasis.

[4] D. Collen,et al. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. , 1985, The Journal of pharmacology and experimental therapeutics.

[5] V. Marder,et al. PLASMIN DEGRADATION OF CROSS‐LINKED FIBRIN * , 1983, Annals of the New York Academy of Sciences.

[6] P. Gaffney,et al. The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D dimer-E. , 1979, Thrombosis research.